COVID-19 Spreads Through Psych Wards; Liquid Quetiapine OK’d

Patients admitted to inpatient psychiatric wards were more likely to contract COVID-19 than those in the community, a retrospective study from London found. (The Lancet Psychiatry)
LGBTQ teens and young adults are experiencing much higher rates of anxiety and depression during the pandemic relative to straight youths, with 75% reporting increased loneliness during this time. (NBC News)
OWP Pharmaceuticals announced that the FDA approved the first-ever liquid formulation of quetiapine fumarate for the treatment of schizophrenia and bipolar disorder.
Following the FDA’s boxed warning on antidepressants in 2003 regarding suicidality, adolescent suicides quickly spiked thanks to declines in depression treatment. “Our findings suggest the boxed warnings may have contributed to the very thing the FDA was trying to prevent,” said study lead author Stephen Soumerai, ScD, of Harvard Medical School and the Harvard Pilgrim Health Care Institute in Boston. (Psychiatric Research and Clinical Practice)